Analysts think BBLG stock price could increase by 1002%
Aug 30, 2024, 6:25 AM
51.61%
What does BBLG do
Bone Biologics, headquartered in Burlington, Massachusetts, focuses on developing bone graft substitutes for spinal fusion using the proprietary protein NELL-1 in combination with demineralized bone matrix (DBM). The company went public on November 27, 2015, and employs two full-time staff.
3 analysts think BBLG stock price will increase by 1002.26%. The current median analyst target is $17.09 compared to a current stock price of $1.55. The lowest analysts target is $16.92 and the highest analyst target is $17.59.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
